Navigation Links
Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases
Date:3/21/2011

ons.

"Late last week, Highmark indicated that it is prepared to provide exemptions of its single therapy requirement for children currently stable on 'non-preferred' products and for patients with a history of intolerable adverse reactions when switched. But, using figures provided by Highmark, they know that this ignores 85% of the affected patient base, the adults with primary immunodeficiency diseases," added Dr. Blaese. "Why should these adult patients be forced to go back and fail on a new therapy, when they are already stabilized?"

"And, what happens to 17 year-olds who turn 18 in a few months?  Will they now be penalized for becoming an adult?" added Dr. Blaese. "Even with the newer Highmark revisions, they may need to switch to a different therapy and risk adverse reactions, even though they've been stabilized for years. And this is hoisted onto them just at the time in their lives when they graduate high school, seek new careers, go to college and face other major transitions."

Last week, IDF launched the "Highmark Is Not My Doctor" campaign with the goal of reversing Highmark's April 1 introduction of the new formulary and to generate awareness among physicians, patients, policymakers and the public about the harmful effects of this action. The campaign includes a blog site, www.HighmarkIsNotMyDoctor.com, to provide information about primary immunodeficiency disease and to educate patients and physicians about the new formulary and what to do to join in the opposition.

"Doctors should decide which therapy is best for a patient's health, not Highmark. 'Failure first' medicine should never be an option when treating a patient – this is a terrible precedent that Highmark is setting and totally unnecessary, stated Lawrence A. LaMotte, Director of Public Policy at IDF. "For the past several months, we have talked to Highmark about the need to reconsider this draconian pla
'/>"/>

SOURCE Immune Deficiency Foundation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Women Get Short Shrift in Many Heart Device Studies, Despite Requirement
2. Report: Inappropriate Antibiotic Use Still High Despite Educational Efforts
3. Parents Continue to Give Cough and Cold Meds to Young Kids, Despite FDA Warnings
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. Half of All Women Do Not Get Regular Mammograms Despite Recommended Guidelines
6. Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents
7. Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010
8. NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges
9. Despite Potential Risk of Serious Birth Defects, New Study Finds Poor Adherence to Oral Contraception among Women on Category X Medications
10. Despite Dramatic Changes, the Crohns Disease Drug Market Will Experience Only Moderate Growth Through 2019
11. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) (Intercept), ... and commercialization of novel bile acid therapeutics to treat ... announced that Mark Pruzanski , MD, ... Deutsche Bank Securities 38th Annual Health Care Conference in ... 2013 at 4:10 p.m. ET. About Intercept ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 23, 2013  PAREXEL International Corporation (NASDAQ: ... at the Jefferies Healthcare Conference in New York.  ... Chief Financial Officer, will be making a presentation on ... Monday, June 3, 2013. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2PAREXEL International To Present At Jefferies Healthcare Conference 2
... March 20, 2012  OriGene Technologies today announced the ... and extensively validated monoclonal antibodies under the UltraMAB™ ... antibodies which are exclusively developed by OriGene for ... products available on the market that have been ...
... YORK, March 20, 2012 Reportlinker.com announces that ... its catalogue: The Outlook ... http://www.reportlinker.com/p0192645/The-Outlook-for-Medical-Devices-in-Central-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Facility The ... total market of 303 million people and a ...
Cached Medicine Technology:OriGene Technologies Announces the Release Specificity-Verified UltraMAB™ Antibodies 2The Outlook for Medical Devices in Central Asia 2The Outlook for Medical Devices in Central Asia 3The Outlook for Medical Devices in Central Asia 4
(Date:5/23/2013)... City, UT (PRWEB) May 23, 2013 ... , a comprehensive radiology learning environment for all ... prebuilt lessons and assessments, transforms the learning experience ... radiology curriculum. , “Until RADPrimer 3.0, ... second to none,” comments Dr. B.J. Manaster, Professor ...
(Date:5/23/2013)... Memorial Day Focus Spotlight on Military ... a part of the U.S. Military for more than ... it, these men and women will be honored for ... America. As veterans transition to civilian life, there ... workplace chaplaincy world. , Marketplace Chaplains, America’s original ...
(Date:5/23/2013)... Susquehanna Health is now a ... training course for adolescents age 11 and up. ... Dr. Patricia Keener after a colleague’s toddler choked to ... who didn’t know how to provide first aid. Safe ... medical basis that aims to reduce the number of ...
(Date:5/23/2013)... next generation genomic analysis to determine that some of ... origins, which may help in predicting cancer progression. The ... Research . , "This is the first study to ... Gleason patterns in the same tumor allowing us to ... M.D., Mayo Clinic pathologist and one of the authors ...
(Date:5/23/2013)... May 23, 2013 Dr. Katherine Ahn ... charitable organization in Orange County, OCCares , will hold ... County. The event details are as follows: , Sunday ... Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 , The ... music by Christian vocalists Charmaine & Jonathan Thulin. There ...
Breaking Medicine News(10 mins):Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3
... TORONTO, Oct. 26 HearAtLast, Inc., (Pink,Sheets: HRAL) announced ... the company. HearAtLast, Inc. The research report,provides an investment ... summary of the Company as an investment opportunity, an,overview ... a,discussion of the company,s industry. To read the report ...
... November 8 and 9, 2007, PENSACOLA, Fla., ... excited to be a major sponsor for this ... leaders in,healthcare, the Department of Defense, Veterans Administration, ... find solutions,for strategic health intelligence. This summit represents ...
... Actively ... Engaged In Community Service, CHICAGO, Oct. 26 Banco Popular ... leading U.S.,Small Business Administration Lender, today announced its nationwide,participation in Make ... taken part of this special national day of,helping others for six ...
... small but revealing study from the Johns Hopkins Childrens ... physical, emotional and psychological functioning and well-being in children ... the children with some of the most severe bladder ... possibility is that children with such conditions manage to ...
... IND proposes a randomized Phase,III pivotal clinical trial ... versus BSC alone for the treatment of patients ... stomach who,have failed adjuvant or 1st or 2nd ... and will direct the clinical development program. The,Company ...
... Oct. 26 Applying quality initiatives,to sales and ... "Managing Quality to Drive Growth," the third quarter,conference ... executives from 20 leading companies discussed hot-button issues,around ... into,sales, marketing and new product development. "We ...
Cached Medicine News:Health News:Harbinger Research Initiates Coverage on HearAtLast 2Health News:Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit 2Health News:Banco Popular Commits To Make A Difference Day 2007 2Health News:Banco Popular Commits To Make A Difference Day 2007 3Health News:Banco Popular Commits To Make A Difference Day 2007 4Health News:Quality-of-life yardstick needed for children with serious urologic conditions, Hopkins study shows 2Health News:Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract 2Health News:Tailor Quality Initiatives to Improve Sales, Marketing & New Product Development 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: